Related Experiment Videos
Does p53 status influence tumor response to anticancer therapies?
K F Pirollo1, K B Bouker, E H Chang
1Department of Oncology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
Anti-Cancer Drugs
|September 23, 2000
Summary
Mutations in the p53 tumor suppressor gene are common in human cancers. Restoring functional p53 may improve cancer treatment sensitivity to chemotherapy and radiotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 tumor suppressor gene is frequently altered in human cancers, affecting over 60% of cases.
- p53 plays a critical role in regulating cell growth and apoptosis, making its status a key factor in tumor response to therapy.
Purpose of the Study:
- To review the relationship between functional p53 status and tumor sensitivity or resistance to chemotherapy and radiotherapy.
- To discuss the potential of gene therapy approaches for restoring functional p53 in tumors to enhance treatment efficacy.
Main Methods:
- Literature review examining studies on p53 gene status and its correlation with treatment outcomes.
- Analysis of current gene therapy strategies aimed at reintroducing functional p53.
Main Results:
- Functional p53 is associated with increased sensitivity to chemotherapy and radiotherapy.
- Non-functional p53 often correlates with resistance to these standard cancer treatments.
Conclusions:
- The p53 gene's functional status is a significant determinant of tumor response to chemotherapy and radiotherapy.
- Restoring functional p53 through gene therapy presents a promising strategy for overcoming treatment resistance in cancer.